Both in Pharmaceuticals
Immuneering vs Vanda Pharmaceuticals
Over the past year IMRX returned −43.9% and VNDA returned −16.1%; their daily moves had a correlation of 0.27.
IMRX −43.9% VNDA −16.1%Growth of $1, one year, split-adjusted
| Metric | IMRX | VNDA |
|---|---|---|
| Price | $3.68 | $3.75 |
| Market cap | $238.3M | $226.8M |
| Today | +5.44% | −3.35% |
| 1 month | −8.9% | −18.1% |
| 6 months | −31.1% | −49.3% |
| Year to date | −44.1% | −57.5% |
| 1 year | −46.4% | −13.8% |
| Revenue growth (YoY) | — | +24.1% |
| Gross margin | — | 94.1% |
| Net margin | — | −32.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.0× |
| Net cash | $145.4M | $138.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.8% | 39.0% |
| Short % of float | 29.2% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).